T ransient myocardial ischemia during daily life has been shown to predict increased risk of coronary events in patients with unstable angina,1-3 with chronic stable angina,4-6 after myocardial infarction,78 and undergoing vascular surgery.9,10 However, coronary atherosclerosis has a patchy evolution, and a single measure of ischemia may not predict increased risk over long periods of time. The purpose of the present study was to determine if evidence of ischemia in ambulatory continuous electrocardiographic monitoring indicates increased risk that continues over time and the validity of using continuous electrocardiographic monitoring to assess risk when patients are on medical therapy.
Methods
One hundred thirty-eight patients with stable symptoms of coronary artery disease on routine medical therapy were recruited for continuous electrocardiographic monitoring if they had symptomlimited exercise tolerance tests that demonstrated horizontal or downsloping ST segment depression of 1 mm or more. The presence of coronary artery disease was documented in 100 of the 138 patients (72%) by angiographic evidence of 70% stenosis of one or more coronary arteries. Among the remaining 38 patients, five had documented previous myocardial infarction, and 33 had exercise tolerance tests that were highly predictive for coronary artery disease (2 mm or greater ST segment depression in association with anginal symptoms [n=26] or reperfusion defect on thallium-201 imaging [n=7] ). Patients on digoxin or with electrocardiographic abnor-malities known to influence the ST segment (e.g., left ventricular hypertrophy, bundle branch block, WolffParkinson-White syndrome, or significant baseline ST segment abnormalities) were not recruited for this study." The initial follow-up of 86 patients at 12 months was reported previously. 12 
Patient Characterization
All patients were characterized according to age, sex, history of myocardial infarction, previous revascularization with coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty, measurement of risk factors, history of angina, coronary angiography results, and left ventricular ejection fraction. Angina pectoris was classified according to New York Heart Association functional class severity.
Diagnostic Testing
All medication was discontinued 48 hours before monitoring and exercise testing in 105 patients. During this period, patients were instructed to take nitroglycerin only as needed for symptoms. In 26 of these patients, the diagnostic testings were repeated while they were on their usual medication. In addition to the 105 patients, 33 patients had their monitoring and exercise testing performed only while they were on their usual medication.
Ambulatory during the monitoring period. Also, the total number of episodes, total ischemic time per 24 hours, and duration per episode were recorded. For each individual episode, heart rate at 5 minutes before onset, heart rate at onset, heart rate at peak of ST segment change, maximal degree of ST segment depression, and association with symptoms were recorded.
Exercise tolerance testing. Maximal symptom-limited exercise tolerance tests were performed on a treadmill using the Bruce protocol. The tests were performed with or without medication in accordance with the ambulatory electrocardiographic monitoring to follow. Exercise tolerance tests were terminated at exhaustion or with the development of 4 mm or greater ST depression, severe angina, three or more premature ventricular contractions in succession, dyspnea, claudication, or a decrease in blood pressure of more than 20 mm Hg. Time to onset of ST depression, heart rate and blood pressure at onset of 1 mm of ST segment depression and at peak exercise, exercise duration, and maximum ST segment depression were recorded for each test.
Follow-up
Subjects were contacted at 3-6-month intervals from the time of initial monitoring to determine the occurrence of death, myocardial infarction, and need for revascularization with coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty because of new or worsening symptoms. These decisions were determined independently by the clinicians without knowledge of the monitoring results. In-hospital records and physician charts were reviewed for confirmation. Deaths were classified as cardiac or noncardiac. Myocardial infarctions were confirmed by standard electrocardiographic evolution and creatine phosphokinase isoenzyme patterns.'0
The physicians caring for patients during the follow-up were blinded to the result of the electrocardiographic monitoring and independently determined the need of medication change or revascularization. (Table 3) . In 105 patients who were monitored off medication, the Kaplan-Meier actuarial analysis of cumulative survival free of myocardial infarction or death is shown in Figure 1 . At 24 months, no deaths or myocardial infarctions had occurred in patients who had no ischemia on ambulatory electrocardiographic monitoring, whereas those who had ischemia had six events. Cox regression analysis showed that the presence of ischemia on monitoring was the only significant predictor for death or myocardial infarctions with follow-up truncated at 2 years (p=0.02) with a relative risk of more than 10. The variables measured during ambulatory electrocardiographic monitoring and exercise testing were then used as time-varying covariates with no influence after 2 years. At 60 months, there was a total of eight events in the ischemia group and two events in patients without ST depression. The 
STD
No STD Death (n) 7 2 MI (n) 6 3 Death or MI (n) 9 4 CABG (n) 21 7 PTCA (n) 1 6 Any event (n) 25 If all events were combined (i.e., death, myocardial infarction, revascularization), the prognosis was clearly worse in the group with ischemia on ambulatory electrocardiographic monitoring at all follow-up times with a relative risk of 2.82 (25 versus 7 events; confidence limits, 1.2 to 6.5; p=0.009), whereas time to ST depression during exercise testing had a relative risk of 1.34 (confidence limits, 1.0 to 1.9) ( Figure  2 ). Symptoms did not appear to have independent predictive value; with or without symptoms, ST segment depression predicted a worse outcome ( Figure  2) . Interestingly, patients who had symptomatic ischemia tended to have events occur sooner. By multivariate analysis, ischemia on ambulatory electrocardiographic monitoring was the only factor that predicted cardiac events independently.
The Kaplan-Meier survival curve for patients who were monitored on medication only is shown in Figure 3 . Compared with patients who had no ischemia while being monitored off medication, the patients who had no ischemia while on medication had worse prognoses (relative risk, 3.68; 95% confidence limits, 1.2 to 10.8; p =0.02), similar to those who had ischemia while off medication.
Further survival analyses of the ambulatory monitoring results examining the number of episodes of ischemia, total ischemic time, or heart rate at onset did not provide additional prognostic information in these patients with stable angina. In patients who are monitored while off medication, the prognostic value of silent ischemia for identifying high-risk patients with stable coronary artery disease is consistent with our previous shortterm follow-up4 and the study by Deedwania and Carbajal.6 However, in the present study, we also demonstrate that the prognostic value of ambulatory electrocardiographic monitoring diminishes over time, especially in predicting the "hard" end points. This is not surprising given that coronary disease has a patchy evolution and a stuttering course. [16] [17] [18] It is likely but not proven that patients who have no ischemia during initial testing may eventually enter an active phase of disease, resulting in myocardial infarction and death. Most of the other prognosis studies have lacked sufficient follow-up to show this time dependency. The event rate in the present study is lower than that reported by Deedwania and Carbajal.6 In that study, patients had a higher rate of ischemia on medication (death rate, 11 of 46, or 24%, in patients with ischemia). However, the overall event rate of 13% at 2 years in patients who did not have ischemia was comparable to the rate (18%) in our cohort of patients who had no ischemia on medication at 2 years. This event rate was substantially higher than the event rate (7%) of patients who had no ischemia while off medication. Thus, the results of these two studies are complementary, reflecting the heterogeneous severity of risk and outcomes in a group of patients who appear to have stable coronary artery disease. The lesser degree of ischemia in our cohort of patients may also explain why the exercise test variables did not have strong predictive values in patients who had positive exercise tests as inclusion criteria. '9,20 In the present study, patients who had no ischemia while monitored only on medication (18 of 33) 
Conclusions
In the present study, we confirmed that asymptomatic ischemia on ambulatory electrocardiographic monitoring predicts the increase risk of cardiac events. The absence of ischemia while off medication is predictive of essentially event-free survival for 2 years, after which cardiac events began to occur 
